Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions

Asaf Maoz, View ORCID ProfileCarter Merenstein, View ORCID ProfileYusuke Koga, Austin Potter, Adam C. Gower, Gang Liu, Sherry Zhang, Hanqiao Liu, Christopher Stevenson, Avrum Spira, Mary E. Reid, View ORCID ProfileJoshua D. Campbell, View ORCID ProfileSarah A. Mazzilli, Marc E. Lenburg, View ORCID ProfileJennifer E. Beane
doi: https://doi.org/10.1101/2021.02.25.21252467
Asaf Maoz
1Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA 02118, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carter Merenstein
1Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA 02118, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carter Merenstein
Yusuke Koga
2Boston University, Bioinformatic Program, Boston, MA 02118, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yusuke Koga
Austin Potter
1Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA 02118, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam C. Gower
1Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA 02118, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gang Liu
1Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA 02118, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherry Zhang
1Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA 02118, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanqiao Liu
1Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA 02118, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Stevenson
3Janssen Research and Development, High Wycombe HP12 4DP, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Avrum Spira
1Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA 02118, USA.
4The Lung Cancer Initiative at Johnson and Johnson, Cambridge MA 02142, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary E. Reid
5Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua D. Campbell
1Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA 02118, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joshua D. Campbell
Sarah A. Mazzilli
1Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA 02118, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah A. Mazzilli
Marc E. Lenburg
1Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA 02118, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer E. Beane
1Boston University School of Medicine, Section of Computational Biomedicine, Boston, MA 02118, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jennifer E. Beane
  • For correspondence: jbeane{at}bu.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective The immune response to invasive carcinoma has been the focus of published work, but little is known about the adaptive immune response to bronchial premalignant lesions (PMLs), precursors of lung squamous cell carcinoma. This study was designed to characterize the T cell receptor (TCR) repertoire in PMLs and its association with clinical, pathological, and molecular features.

Methods Endobronchial biopsies (n=295) and brushings (n=137) from high-risk subjects (n=50), undergoing lung cancer screening at approximately 1-year intervals via autofluorescence bronchoscopy and CT, were profiled by RNA-seq. We applied the TCR Repertoire Utilities for Solid Tissue/Tumor (TRUST) tool to the RNA-seq data to identify TCR CDR3 sequences across all samples. In the biopsies, we measured the correlation of TCR diversity with previously derived immune-associated PML transcriptional signatures and outcome. We also quantified the spatial and temporal distribution of shared and clonally expanded TCRs. Using the biopsies and brushes, the ratio of private (i.e., found in one patient only) and public (i.e., found in two or more patients) TCRs was quantified and the CDR3 sequences were compared to those found in curated databases with known antigen specificities.

Results We detected 39,303 unique TCR sequences across all samples. In PML biopsies, TCR diversity was negatively associated with a transcriptional signature of T-cell mediated immune activation (Spearman’s rho −0.34, p < 0.001) associated with PML outcome.

Additionally, in lesions of the proliferative molecular subtype, TCR diversity was decreased in regressive versus progressive/persistent PMLs (p=0.045). Within each patient, TCRs were more likely to be shared between biopsies sampled at the same timepoint than biopsies sampled at the same anatomic location at different times. Clonally expanded TCRs, within a biopsied lesion, were more likely to be expanded at future time points than non-expanded clones. The majority of TCR sequences were found in a single sample, with only 3,396 (8.6%) found in more than one sample and 1,057 (2.7%) found in two or more patients (i.e. public), however, when compared to a public database of CDR3 sequences, 4,543 (11.6%) of TCRs were identified as public. TCRs with known antigen specificities were enriched among Public TCRs (p < 0.001).

Conclusions Decreased TCR diversity may reflect nascent immune responses that contribute to PML elimination. Further studies are needed to explore the potential for immunoprevention of PMLs.

Competing Interest Statement

JEB, SAM, JDC, MER, AES and MEL received commercial research grants from Janssen Pharmaceuticals. MEL is a consultant to Veracyte. AES and CS are employed by Johnson and Johnson.

Funding Statement

This study was supported by funding from Janssen Research and Development (PIs: JEB, SAM, JDC) and by a Stand Up To Cancer-LUNGevity-American Lung Association Lung Cancer Interception Dream Team Translational Cancer Research Grant (grant number: SU2C-AACR-DT23-17 to S.M. Dubinett and A.E. Spira). Stand Up To Cancer is a division of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Institutional Review Boards at Boston University Medical Center and Roswell Comprehensive Cancer Center approved the study and all subjects provided written informed consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Corrected spelling of the 1st author's name

Data Availability

RNA sequencing data from human endobronchial biopsies and brushings has been previously deposited in the NCBI Gene Expression Omnibus under accession code GSE109743.

http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109743

  • List of abbreviations

    PML
    premalignant lesion
    CPK
    clonotypes per kilobase
    TCR
    T cell receptor
    PCGA
    Pre-Cancer Genome Atlas
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted March 03, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions
    Asaf Maoz, Carter Merenstein, Yusuke Koga, Austin Potter, Adam C. Gower, Gang Liu, Sherry Zhang, Hanqiao Liu, Christopher Stevenson, Avrum Spira, Mary E. Reid, Joshua D. Campbell, Sarah A. Mazzilli, Marc E. Lenburg, Jennifer E. Beane
    medRxiv 2021.02.25.21252467; doi: https://doi.org/10.1101/2021.02.25.21252467
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Elevated T cell repertoire diversity is associated with progression of lung squamous cell premalignant lesions
    Asaf Maoz, Carter Merenstein, Yusuke Koga, Austin Potter, Adam C. Gower, Gang Liu, Sherry Zhang, Hanqiao Liu, Christopher Stevenson, Avrum Spira, Mary E. Reid, Joshua D. Campbell, Sarah A. Mazzilli, Marc E. Lenburg, Jennifer E. Beane
    medRxiv 2021.02.25.21252467; doi: https://doi.org/10.1101/2021.02.25.21252467

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Respiratory Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)